$PG · The Procter & Gamble Company

The Procter & Gamble Company filed a Form 4 with the SEC on November 3, 2026, reporting a change in beneficial ownership by Paul Gama, who is identified as CEO – Health Care. The filing discloses a transaction dated October 30, 2026, involving the company’s common stock.

According to the report, Gama sold 2,894 shares of common stock at a price of $165 per share. Following that sale, he directly held 43,898.8803 shares. The filing also lists an additional 1,183.969 shares held indirectly through a retirement plan trustee.

The Form 4 does not indicate that the sale was made pursuant to a pre-arranged Rule 10b5-1 trading plan, as that box was not checked. The form was signed on his behalf by an attorney-in-fact on November 3, 2026.